Literature DB >> 2157564

Effects of 3-deoxyglucosone on the Maillard reaction.

N Igaki1, M Sakai, H Hata, M Oimomi, S Baba, H Kato.   

Abstract

We investigated the effect of exogenously applied 3-deoxyglucosone, a major carbonyl intermediate, on the Maillard reaction. The fluorescence intensity of the product of the reaction of bovine serum albumin with 3-deoxyglucosone was higher than that with an equivalent amount of glucose. Similarly the rate of polymerization of lysozyme in the presence of 3-deoxyglucosone was also greater than with glucose, and collagen incubated with 3-deoxyglucosone was less digestible than collagen incubated with glucose. By contrast, aminoguanidine inhibited an increase in fluorescence of the Maillard compounds and the polymerization of protein, both of which were stimulated by 3-deoxyglucosone. These results suggest that 3-deoxyglucosone accelerates the advanced stage of the Maillard reaction and that aminoguanidine acts on 3-deoxyglucosone to inhibit its action in the advanced stage of the Maillard reaction.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2157564

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  4 in total

1.  L-Arginine inhibits in vitro nonenzymatic glycation and advanced glycosylated end product formation of human serum albumin.

Authors:  D A Servetnick; D Bryant; K J Wells-Knecht; P L Wiesenfeld
Journal:  Amino Acids       Date:  1996-03       Impact factor: 3.520

2.  A new neutral-pH low-GDP peritoneal dialysis fluid.

Authors:  Rainer Himmele; Lynn Jensen; Dominik Fenn; Chih-Hu Ho; Dixie-Ann Sawin; Jose A Diaz-Buxo
Journal:  Perit Dial Int       Date:  2012-03-01       Impact factor: 1.756

3.  Prevention of diabetes-induced albuminuria in transgenic rats overexpressing human aldose reductase.

Authors:  Daniel P K Ng; Charles L Hardy; Wendy C Burns; Evelyne E Muggli; Nicole Kerr; Jane McCausland; Daine Alcorn; Timothy E Adams; Jeffrey D Zajac; Richard G Larkins; Marjorie E Dunlop
Journal:  Endocrine       Date:  2002-06       Impact factor: 3.633

4.  In vivo monitoring of serum protein cross linking in patients with diabetes mellitus. Evidence for pharmacological modification of immunoglobulin G cross links.

Authors:  B Lubec; M Weninger; C Popow; H Vierhapper; J Lunec; G Lubec
Journal:  Amino Acids       Date:  1993-02       Impact factor: 3.520

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.